These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 872302)

  • 1. The C19-mineralocorticoids in hypertension.
    Sennett JA; Yarbro LR; Slaton PE; Hollifield JW; Liddle GW
    Circ Res; 1977 Aug; 41(2):260-4. PubMed ID: 872302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New mineralcorticoids in the syndrome of low-renin essential hypertension.
    Liddle GW; Sennett JA
    J Steroid Biochem; 1975 May; 6(5):751-3. PubMed ID: 127083
    [No Abstract]   [Full Text] [Related]  

  • 3. Mineralocorticoid activity of 16beta-hydroxydehydroepiandrosterone and related steroids.
    Gomez-Sanchez C; Holland OB; Higgins JR; Mathieu R; Gruber GM; Milewich L; Kaplan NM
    J Lab Clin Med; 1976 Oct; 88(4):571-7. PubMed ID: 135037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a new mineralocorticoid in patients with low-renin essential hypertension.
    Sennett JA; Brown RD; Island DP; Yarbro LR; Watson JT; Slaton PE; Hollifield JW; Liddle GW
    Circ Res; 1975 Jun; 36(6 Suppl 1):2-9. PubMed ID: 124232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure changes following chronic administration to rats of 3beta,16beta-dihydroxy-5-androsten-17-one, 3beta,17beta-dihydroxy-5-androsten-16-one and 21-hydroxy-4-pregnene-3,20-dione-21-acetate.
    Ogihara T; Ichihara K; Yamamoto T; Kumahara Y; Kircher HW; Nugent CA
    Steroids; 1977 Jan; 29(1):17-20. PubMed ID: 138980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.
    Baxter JD; Schambelan M; Matulich DT; Spindler BJ; Taylor AA; Bartter FC
    J Clin Invest; 1976 Sep; 58(3):579-89. PubMed ID: 182723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma 16 beta-hydroxydehydroepiandrosterone in normal and pathological conditions in man.
    Sekihara H; Sennett JA; Liddle GW; McKenna TJ; Yarbro LR
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1078-84. PubMed ID: 186475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 19-Noraldosterone in pregnancy-induced hypertension.
    Takeda Y; Yoneda T; Demura M; Furukawa K; Usukura M; Mabuchi H
    Steroids; 2002 Jun; 67(7):605-10. PubMed ID: 11996933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of 16beta-hydroxydehydroepiandrosterone with renal mineralocorticoid receptors.
    Higgins JR; Wambach G; Kem DC; Gomez-Sanchez C; Holland OB; Kaplan NM
    J Lab Clin Med; 1977 Feb; 89(2):250-6. PubMed ID: 137938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma renin and aldosterone in an abdominal pregnancy with toxemia.
    Baehler RW; Copeland WE; Stein JH; Ferris TF
    Am J Obstet Gynecol; 1975 Jul; 122(5):545-8. PubMed ID: 1146920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for heterogeneity of mineralocorticoids in urine of patients with low renin essential hypertension.
    Sekihara H; Hollifield JW; Island DP; Slaton PE; Liddle GW
    J Clin Endocrinol Metab; 1979 Jan; 48(1):143-7. PubMed ID: 422696
    [No Abstract]   [Full Text] [Related]  

  • 12. New mineralocorticoids and adrenocorticosteroids in hypertension.
    Melby JC; Dale SL
    Am J Cardiol; 1976 Nov; 38(6):805-13. PubMed ID: 136892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease.
    McQuarrie EP; Freel EM; Mark PB; Fraser R; Connell JM; Jardine AG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1526-32. PubMed ID: 23413088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 18-hydroxylated cortisols in hypertension.
    Gomez-Sanchez CE; Gomez-Sanchez EP; Holland OB
    J Steroid Biochem; 1987; 27(4-6):971-5. PubMed ID: 3320570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary kallikrein in normal pregnancy, pregnancy with hypertension, and toxemia.
    Kovatz S; Arber I; Korzets Z; Rathaus M; Ben Aderet N; Bernheim J
    Nephron; 1985; 40(1):48-51. PubMed ID: 3858700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension.
    Taylor AA; Mitchell JR; Bartter FC; Snodgrass WR; McMurtry RJ; Gill JR; Franklin RB
    J Clin Invest; 1978 Jul; 62(1):162-8. PubMed ID: 149141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential changes in the renin--angiotensin--aldosterone systems and plasma progesterone concentration in normal and abnormal human pregnancy.
    Weinberger MH; Kramer NJ; Petersen LP; Cleary RE; Young PC
    Perspect Nephrol Hypertens; 1976; 5():263-9. PubMed ID: 1005040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there unknown mineralocorticoids in low-renin essential hypertension?
    Hollifield JW; Slaton PE; Wilson HM; Sennett JA; Yarbro L; Island DP; Liddle GW
    Mayo Clin Proc; 1977 May; 52(5):329-33. PubMed ID: 323587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
    Chobanian AV; Gavras H; Melby JC; Gavras I; Jick H
    Trans Assoc Am Physicians; 1978; 91():368-80. PubMed ID: 754399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity.
    Messerli FH; Kuchel O; Nowaczynski W; Seth K; Honda M; Kubo S; Boucher R; Tolis G; Genest J
    Circulation; 1976 Mar; 53(3):406-10. PubMed ID: 1248073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.